Co-Diagnostics, Inc.
CODX
$0.35
-$0.01-2.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -22.34% | -71.09% | -91.70% | -94.70% | -97.10% |
| Total Other Revenue | -45.97% | 186.35% | -- | -- | -- |
| Total Revenue | -42.53% | 57.16% | 25.24% | -44.91% | -80.09% |
| Cost of Revenue | -76.13% | 114.20% | 63.48% | 45.01% | -23.65% |
| Gross Profit | 11.00% | 23.37% | 8.24% | -70.69% | -90.86% |
| SG&A Expenses | -2.36% | -8.60% | -11.82% | 0.72% | -2.16% |
| Depreciation & Amortization | 11.93% | 9.61% | 3.72% | -7.87% | -4.08% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.15% | 2.27% | 2.86% | 14.27% | 8.10% |
| Operating Income | 6.15% | 3.88% | 1.31% | -37.14% | -268.44% |
| Income Before Tax | 1.39% | 28.54% | 24.92% | 1.45% | -102.21% |
| Income Tax Expenses | 102.07% | 139.99% | 118.09% | 94.00% | 39.73% |
| Earnings from Continuing Operations | -6.53% | 3.00% | 0.98% | -22.65% | -148.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.53% | 3.00% | 0.98% | -22.65% | -148.15% |
| EBIT | 6.15% | 3.88% | 1.31% | -37.14% | -268.44% |
| EBITDA | 6.68% | 4.29% | 1.47% | -39.17% | -302.34% |
| EPS Basic | -2.99% | 4.52% | 1.52% | -24.37% | -130.88% |
| Normalized Basic EPS | 8.68% | 6.32% | 2.11% | -41.46% | -255.72% |
| EPS Diluted | -2.52% | 4.87% | 2.08% | -24.20% | -130.31% |
| Normalized Diluted EPS | 8.68% | 6.32% | 2.11% | -41.46% | -249.94% |
| Average Basic Shares Outstanding | 3.35% | 2.05% | -0.57% | -4.16% | -7.79% |
| Average Diluted Shares Outstanding | 3.35% | 2.05% | -0.57% | -4.16% | -8.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |